L-DABA (hydrobromide)
L-DABA (L-2,4-Diaminobutyric acid) hydrobromide is a week GABA transaminase inhibitor with an IC50 of larger than 500 μM; exhibits antitumor activity in vivo and in vitro.
Product Specifications
CAS Number
73143-97-2
Product Name Alternative
L-2,4-Diaminobutyric acid (hydrobromide)
UNSPSC
12352211
Hazard Statement
H302, H315, H319, H335
Target
Endogenous Metabolite; GABA Receptor
Type
Reference compound
Related Pathways
Membrane Transporter/Ion Channel; Metabolic Enzyme/Protease; Neuronal Signaling
Applications
Cancer-programmed cell death
Field of Research
Cancer; Neurological Disease
Assay Protocol
https://www.medchemexpress.com/l-daba-hydrobromide.html
Purity
98.0
Solubility
DMSO : 23 mg/mL (ultrasonic)
Smiles
NCC[C@H](N)C(O)=O.[H]Br
Molecular Formula
C4H11BrN2O2
Molecular Weight
199.05
Precautions
H302, H315, H319, H335
References & Citations
[1]Ronquist G, et al. Antitumor activity of L-2,4 diaminobuturic acid against mouse fibrosarcoma cells in vitro and in vivo. J Cancer Res Clin Oncol. 1980;96 (3) :259-68.|[2]Beart PM, et al. l-2,4-Diaminobutyric acid and the GABA system. Neurosci Lett. 1977 Jul;5 (3-4) :193-8.|[3]Panasci L, et al. The cytolytic effect of L-2,4 diaminobutyric acid with malignant glioma cells and fibroblasts. Cancer Chemother Pharmacol. 1988;21 (2) :143-4.
Shipping Conditions
Room Temperature
Storage Conditions
4°C (Powder, sealed storage, away from moisture)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
MBS6271307-01 0.1 mL
ACTL7B, NT (ACTL7B, Actin-like protein 7B, Actin-like-7-beta) (MaxLight 650)
Sign In for Pricing
View Details MBS6271307-02 5x 0.1 mL
ACTL7B, NT (ACTL7B, Actin-like protein 7B, Actin-like-7-beta) (MaxLight 650)
Sign In for Pricing
View Details